BR9914570A - Processo para o tratamento da esquizofrenia bem como agentes para o emprego neste processo - Google Patents

Processo para o tratamento da esquizofrenia bem como agentes para o emprego neste processo

Info

Publication number
BR9914570A
BR9914570A BR9914570-7A BR9914570A BR9914570A BR 9914570 A BR9914570 A BR 9914570A BR 9914570 A BR9914570 A BR 9914570A BR 9914570 A BR9914570 A BR 9914570A
Authority
BR
Brazil
Prior art keywords
schizophrenia
agents
treatment
well
nicotine
Prior art date
Application number
BR9914570-7A
Other languages
English (en)
Inventor
Reinhold Meconi
Volker Siemund
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BR9914570A publication Critical patent/BR9914570A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO PARA O TRATAMENTO DA ESQUIZOFRENIA BEM COMO AGENTES PARA O EMPREGO NESTE PROCESSO"<D>. é descrita administração transdérmica de nicotina ou de um sal de nicotina ou de uma mistura de nicotina e sal de nicotina para o tratamento da esquizofrenia. São publicados um processo e um dispositivo medicinal.
BR9914570-7A 1998-10-16 1999-10-02 Processo para o tratamento da esquizofrenia bem como agentes para o emprego neste processo BR9914570A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19847715A DE19847715A1 (de) 1998-10-16 1998-10-16 Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
PCT/EP1999/007320 WO2000023077A1 (de) 1998-10-16 1999-10-02 Verfahren zur behandlung der schizophrenie sowie mittel zur verwendung in diesem verfahren

Publications (1)

Publication Number Publication Date
BR9914570A true BR9914570A (pt) 2001-07-03

Family

ID=7884666

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914570-7A BR9914570A (pt) 1998-10-16 1999-10-02 Processo para o tratamento da esquizofrenia bem como agentes para o emprego neste processo

Country Status (10)

Country Link
EP (1) EP1121126A1 (pt)
JP (1) JP2002527478A (pt)
KR (1) KR20010080135A (pt)
CN (1) CN1323210A (pt)
AR (1) AR020815A1 (pt)
AU (1) AU6199299A (pt)
BR (1) BR9914570A (pt)
CA (1) CA2341855A1 (pt)
DE (1) DE19847715A1 (pt)
WO (1) WO2000023077A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110953A1 (de) * 2001-03-07 2002-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten
KR20060120156A (ko) * 2003-10-28 2006-11-24 알자 코포레이션 담배의 이용빈도를 감소시키기 위한 방법 및 장치
IL177071A0 (en) * 2005-08-01 2006-12-10 Nitto Denko Corp Method of preparing a nicotine transdermal preparation
US20140155429A1 (en) * 2011-05-09 2014-06-05 Envivo Pharmaceuticals, Inc. Treatment of Cognitive Disorders with Certain Alpha-7 Nicotinic Acid Receptor Agonists in Combination with Nicotine
CZ309812B6 (cs) * 2021-05-25 2023-11-01 Consumer Brands International s.r.o Směs pro výrobu nikotinových sáčků a způsob její výroby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
GB9614902D0 (en) * 1996-07-16 1996-09-04 Rhodes John Sustained release composition
US5776956A (en) * 1996-07-30 1998-07-07 Lectec Corporation Use of cotinine in treating psychiatric disorders
US5776957A (en) * 1996-11-15 1998-07-07 The University Of Kentucky Research Foundation Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states

Also Published As

Publication number Publication date
AR020815A1 (es) 2002-05-29
WO2000023077A1 (de) 2000-04-27
DE19847715A1 (de) 2000-04-20
KR20010080135A (ko) 2001-08-22
AU6199299A (en) 2000-05-08
EP1121126A1 (de) 2001-08-08
JP2002527478A (ja) 2002-08-27
CA2341855A1 (en) 2000-04-27
CN1323210A (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
DE69535684D1 (de) Zusammensetzungen welche DNA zerstoerende Agentien und P53 enthalten
ATE339187T1 (de) Verwendung von zusammensetzungen mit antiseptika und/oder die wundheilung fördernden wirkstoffen für den tieferen atemwegstrakt
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
BR9812484A (pt) Terapia combinada para erradicação de hcv-rna detectável em pacientes com infecção crÈnica por hepatite c
ATE510542T1 (de) Noribogain zur behandlung von schmerzen und drogenabhängigkeit
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
BR0010669A (pt) Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina
ATE198550T1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE187642T1 (de) Verwendund von norastemizol zur behandlung der allergischen rhinitis
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
BR9914570A (pt) Processo para o tratamento da esquizofrenia bem como agentes para o emprego neste processo
HUP0002836A2 (hu) Makrociklusos bisz(3,3&#39;-indolil)-maleinimid-származékok alkalmazása bőrrendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
BR0315609A (pt) Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica
BR9808299A (pt) O uso de levobupivacaìna ou ropivacaìna para o tratamento da enxaqueca
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
BR0315374A (pt) Compostos orgânicos
ATE245421T1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
TR199901385T2 (xx) Piperidin t�revleri.
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.